Answers are grounded in this paper and cite their sources.
Background: Hemophagocytic lymphohistiocytosis (HLH) is rare but very severe clinical syndrome of hyperinammation caused by a dysfunctional decient down regulation of immune response, which leads to potentially life threatening complications. Viral infections with Epstein-Barr virus (EBV) are a well-recognised trigger of HLH but the treatment of such cases is not well-dened. Clinical Description: We describe here a case of 7years old female who developed hepatosplenomegaly and lymphadenopathy that later developed haemorrhagic manifestations, pyomeningitis as neurological manifestation of HLH, who Despite of giving aggressive treatment with multiple agents succumbed to illness. Management: Treatment of secondary HLH can be achieved with the help of the standard HLH-2004 regimen. However, the medication protocol needs to be adapted depending on its cause. Conclusion: This case report aims to underline the diagnostic challenges of HLH, potential of primary EBV infection to cause fulminant HLH, as well as its potentially lethal, haemorrhagic complications. There is meaningful work to continue in the HLH eld, and unremitting efforts that are underway will continue to improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Bhusara et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: